8-K: Current report filing
Published on November 9, 2009
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) November 2, 2009
----------------
REPRO-MED SYSTEMS, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
NEW YORK 0-12305 13-3044880
- ---------------------------- ------------ -------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
24 Carpenter Road, Chester, New York 10918
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (845) 469-2042
--------------
not applicable
--------------------------------------------------------------
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
ITEM 8.01 OTHER EVENTS.
The Company has recently released the enclosed press release relating to a
feature of its RES-Q-VAC suction system which can be used to collect samples for
a wide range of different diseases including the H1N1 (swine influenza), H1N5
(avian influenza), RSV (Respiratory Syncytial Virus), among others.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits.
Exhibit Description
- ------- -----------
99.1 Press release dated November 2, 2009.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
REPRO-MED SYSTEMS, INC.
(Registrant)
Date November 9, 2009 By: /s/ Andrew I. Sealfon
---------------- ---------------------
Andrew I. Sealfon
President and Chief Executive Officer
- 2 -